Phase I dose-escalation study of the pan-HER inhibitor, PF299804, in patients with advanced malignant solid tumors
泛 HER 抑制剂 PF299804 治疗晚期恶性实体肿瘤患者的 I 期剂量递增研究
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-10-1220
Pasi A Jänne, David S Boss, D Ross Camidge, Carolyn D Britten, Jeffrey A Engelman, Edward B Garon, Feng Guo, Steven Wong, Jane Liang, Stephen Letrent, Robert Millham, Ian Taylor, S Gail Eckhardt, Jan H M Schellens